Healthcare Sales & Marketing Network News: OrbiMed

Searching News Database: OrbiMed

HSMN NewsFeed - 5 Nov 2025
Braveheart Bio Launches with $185M Series A Aiming to Transform Care of Hypertrophic Cardiomyopathy
Biopharmaceuticals Cardiology Venture Capital

HSMN NewsFeed - 30 Oct 2025
Brenig Therapeutics Names Megan McGill as Chief Executive Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 27 Aug 2025
Leal Therapeutics Announces $30 Million Series A to Progress First-In-Class Neuro-Metabolic Therapies for Neurodegenerative and Neuropsychiatric Disorders with High-Unmet Need
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 25 Aug 2025
ProVerum Secures $80 Million Series B Financing to Advance New Treatment for BPH
Devices Urology Venture Capital

HSMN NewsFeed - 4 Aug 2025
OrbiMed Raises $1.86 Billion for Healthcare Royalty & Credit Fund V
Devices Biopharmaceuticals Diagnostics Venture Capital

HSMN NewsFeed - 20 Jun 2025
Lomond Therapeutics Announces U.S. FDA Clearance of IND Application for Lonitoclax, a Selective BCL2 Inhibitor with Limited Immune Suppression and Improved Safety Compared to Venetoclax and Venetoclax- Like Molecules
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 15 May 2025
Alpheus Medical Raises $52M in Series B Round to Advance Groundbreaking Glioblastoma Therapy
Devices Oncology Venture Capital

HSMN NewsFeed - 16 Apr 2025
Xtant Medical Announces Secondary Private Sale of Existing Shares by OrbiMed and Preliminary First Quarter 2025 Revenue Growth of 18% to 19%
Devices Orthopaedic Wound Care Venture Capital

HSMN NewsFeed - 31 Mar 2025
Lomond Therapeutics Completes Second and Third Closings and adds Two New Investors
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 3 Sep 2024
Forward Therapeutics Welcomes Ulrich Thienel, M.D., Ph.D. as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Jul 2024
Magenta Medical Closes $105M Financing Led by Novo Holdings
Devices Interventional Cardiology Venture Capital

HSMN NewsFeed - 6 Mar 2024
Sionna Therapeutics Announces $182 Million Series C Financing to Advance Clinical Development of Novel Small Molecules in Cystic Fibrosis
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 13 Feb 2024
ProfoundBio Raises $112 Million in Oversubscribed Series B Equity Financing to Advance its Clinical-Stage Antibody-Drug Conjugate (ADC) Pipeline
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 2 Feb 2024
Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 13 Dec 2023
Triveni Bio Welcomes Jeff Albers and Allison Luo to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Nov 2023
Koya Medical Raises New Capital with OrbiMed to Support Growth
Devices Venture Capital

HSMN NewsFeed - 25 Sep 2023
Adela Announces $48 Million in Financing and Leadership Addition to Advance Tissue-Agnostic Minimal Residual Disease (MRD) Monitoring Product Portfolio Based on Genome-Wide Methylome Approach
Diagnostics Venture Capital

HSMN NewsFeed - 3 May 2023
Convergent Therapeutics Announces $90 Million Series A Financing to Advance the Clinical Development of Radiopharmaceuticals for the Treatment of Prostate Cancer and Other Solid Tumors
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 7 Dec 2022
Apogee Therapeutics Launches with $169 Million to Develop Potentially Best-in-Class Therapies for Immunological and Inflammatory Disorders
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 10 Nov 2022
Lipidio Pharmaceuticals Announces Close of Series A Extension Financing, Bringing Total Round to Over $20M
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 10 Aug 2022
GentiBio Announces Collaboration with Bristol Myers Squibb to Pioneer Engineered Treg Therapies for Inflammatory Bowel Diseases
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 22 Jun 2022
Angiex Strengthens its Leadership Team with the Appointment of Marty J. Duvall as Chief Executive Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 17 Nov 2021
Alpheus Medical Closes $16M In Series A Financing For Novel Glioma Brain Cancer Treatment
Devices Oncology Venture Capital

HSMN NewsFeed - 2 Sep 2021
Chemomab Therapeutics Announces Appointment of Dale Pfost as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Sep 2021
Disc Medicine Announces $90 Million Series B Financing to Advance Portfolio of Clinical-Stage Therapies for Hematologic Diseases
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 11 Aug 2021
GentiBio Announces $157M Series A Financing to Advance Engineered Regulatory T cells as Transformative Therapeutics with Potential to Restore Immune Tolerance and Durably Treat Autoinflammation
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 13 May 2021
SpliSense Secures $28.5 Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 4 May 2021
Theseus Pharmaceuticals Appoints Tim Clackson, Ph.D., as Chief Executive Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 13 Apr 2021
Theseus Pharmaceuticals Debuts with $100M Series B Raise to Develop Pan-Variant Kinase Inhibitors
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 5 Feb 2021
Jubilant Therapeutics Appoints Dr. Robert Glassman to its Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 12 Jan 2021
Delfi Diagnostics Announces $100 Million Series A Financing to Develop a New Class of Early Detection Liquid Biopsy for Multiple Cancers
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 31 Dec 2020
ImmVira Announces Series C Financing with Leading Specialist Investors
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 15 Dec 2020
Lilly Announces Agreement to Acquire Prevail Therapeutics
Biopharmaceuticals Neurology Mergers & Acquisitions

HSMN NewsFeed - 29 Oct 2020
Q32 Bio Closes $60 Million Series B Financing, Advances to Clinical Stage Research in Therapeutics Designed to Restore Immune Homeostasis
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 27 Oct 2020
Steven Yecies Joins Javelin Oncology as Chief Executive Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 27 Oct 2020
Caris Life Sciences Raises $310 Million in Growth Capital from a Broad Syndicate of Leading Investors
Diagnostics Venture Capital Personnel

HSMN NewsFeed - 28 Sep 2020
BioShin, Biohaven's Asia-Pacific Subsidiary, Raises $60M in Series A Funding to Advance Neuroscience Pipeline in Asia-Pacific Region
Biopharmaceuticals Personnel Venture Capital

HSMN NewsFeed - 4 Sep 2020
I-Mab Announces $418 Million Private Placement with Hillhouse Capital-Led Consortium
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 18 Aug 2020
ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 12 Aug 2020
MobileODT completed $4 million series round C
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 1 Apr 2020
Aspen Neuroscience Announces $70 Million Series A Financing Led by OrbiMed to Advance Development of the First Autologous Neuron Replacement Therapy to Treat Parkinson Disease
Regenerative Medicine Neurology Venture Capital

HSMN NewsFeed - 12 Dec 2019
Aspen Neuroscience Launches With $6.5 Million Seed Funding to Advance First-of-its-Kind Personalized Cell Therapy for Parkinson's Disease
Regenerative Medicine Neurology Venture Capital

HSMN NewsFeed - 27 Aug 2019
PIONYR Immunotherapeutics Announces Key Leadership Team Addition and Clinical Candidates Targeting Tumor-Associated Macrophages
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 18 Mar 2019
RDD Pharma Appoints John Temperato as Chief Executive Officer
Biopharmaceuticals Gastroenterology Personnel

HSMN NewsFeed - 25 Feb 2019
Viriom Announces New CEO Appointment
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Jan 2019
Indalo Therapeutics Appoints Seasoned Biopharmaceutical Executive Robert Jacks President & CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Nov 2018
ORIC Pharmaceuticals Appoints Matt Panuwat as Chief Business Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 12 Nov 2018
Arix Bioscience plc: Arix Participates in Harpoon $70m Series C Investment Round
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 5 Nov 2018
Audentes Therapeutics Board of Directors Appoints Co-Founder and Chief Executive Officer Matthew R. Patterson as Chairman
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Oct 2018
89Bio Launches into Liver and Metabolic Disorders with $60 Million Series A Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 17 Sep 2018
ORIC Pharmaceuticals Appoints Pratik Multani, MD, as Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 23 Aug 2018
E-Scape Bio Appoints Biopharma Industry Veteran Julie Anne Smith As President and Chief Executive Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 27 Jun 2018
Adicet Bio appoints Stewart Abbot, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 7 May 2018
ORIC Has Appointed Jacob Chacko, MD as Chief Executive Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 30 Apr 2018
Attenua Raises $35M in Series A Financing to Advance Therapy for Chronic Cough
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 30 Apr 2018
Synthorx Announces $63 Million Series C Financing to Advance a Pipeline of Synthorin(TM) Cytokines
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 30 Apr 2018
Adicet Bio appoints Elizabeth "EJ" Read, M.D. as Chief Technology Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 4 Apr 2018
Arvinas Completes $55 Million Series C Financing to Advance Protein Degradation Platform
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 19 Mar 2018
PMV Pharma Appoints Salim Yazji, M.D. as Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 23 Jan 2018
Skyhawk Therapeutics Launches With $8 Million in Seed Financing to Advance Its Novel Platform and Portfolio of Small Molecules That Correct RNA Expression
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 4 Jan 2018
Neurogastrx, Inc. Raises $45M Series A To Bring Lead GI Candidate Through Proof Of Concept
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 20 Dec 2017
ORIC Has Appointed Rich Heyman, PhD as Acting Chief Executive Officer and Leonard Reyno, MD as Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 5 Dec 2017
PMV Pharma Appoints Winston Kung as COO & CFO
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 4 Dec 2017
Led by OrbiMed Israel and Peter Thiel, ChemomAb Raises $10 Million in Series B Funding
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 16 Nov 2017
RDD Pharma Raises $9.5M in Series B Funding to Fuel Global Development
Biopharmaceuticals Gastroenterology Venture Capital

HSMN NewsFeed - 29 Aug 2017
ARMO BioSciences Raises $67 Million in a Series C-1 Financing
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 12 Jul 2017
E-Scape Bio Series A Extension Brings Total Round to $63 Million to Fund Neurodegenerative Disease Pipeline
Biopharmaceutical Neurology Venture Capital

HSMN NewsFeed - 27 Jun 2017
Mitoconix Bio Raises $20 Million in Series A Funding to Develop Neurodegenerative Disease Therapies
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 15 May 2017
BiomX Raises $24 Million in Series A Funding to Develop Microbiome Therapeutics
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 22 Feb 2017
Symbiomix Therapeutics Appoints David L. Stern as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Nov 2016
Turnstone Biologics Raises $41.4 Million Series B Financing
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 1 Sep 2016
Immune-Onc Therapeutics, Inc. Announces $7 Million Series A Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 12 Aug 2016
Arrowhead Pharmaceuticals Closes $45 Million Private Offering
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 3 Aug 2016
Ornim Raises $20 Million in Latest Equity Financing Round
Devices Monitoring Venture Capital

HSMN NewsFeed - 2 May 2016
Graybug Vision Announces $44.5 Million Series B Financing
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 22 Mar 2016
Acutus Medical Completes $75 Million Series C Financing
Devices Cardiology Venture Capital

HSMN NewsFeed - 27 Jan 2016
Adicet Bio Announces Closing of $51 Million Series A Financing and Acquisition of Applied Immune Technologies
Biopharmaceuticals Venture Capital Mergers & Acquisitions

HSMN NewsFeed - 7 Jan 2016
Guardant Health Secures Series D Financing to Expand the Reach of its Digital Sequencing(TM) Platform in Oncology
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 7 Jan 2016
Alector Announces Closing of Series D Financing
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 6 Jan 2016
NextCure, Inc., New Immuno-Oncology Firm, Announces $67 Million Series A Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 3 Dec 2015
True North Therapeutics Announces $40 Million Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 23 Nov 2015
ObsEva Closes CHF 60 (USD 60) Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 2 Nov 2015
Bristol-Myers Squibb to Acquire Cardioxyl Pharmaceuticals, Inc.
Biopharmaceuticals Cardiology Mergers & Acquisitions

HSMN NewsFeed - 21 Oct 2015
Arvinas Secures $41.6M Series B Financing - Appoints New Board Members
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 29 Sep 2015
Corvus Pharmaceuticals Completes $75 Million Series B Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 8 Sep 2015
Selecta Announces $38 Million Series E Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 1 Sep 2015
Intellia Therapeutics Secures $70 Million in Series B Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 7 Apr 2015
True North Therapeutics Announces $35 Million Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 6 Apr 2015
Natera, Inc., Non-Invasive Genetic Testing Leader, Secures $55 Million in Private Financing
Diagnostics Venture Capital

HSMN NewsFeed - 5 Jan 2015
Aduro Biotech Closes $51.4 Million Series D Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 2 Dec 2014
Audentes Therapeutics Raises $42.5 Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 1 Dec 2014
Ascendis Pharma A/S Completes $60 million Oversubscribed Series D Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 15 Oct 2014
Selecta Announces More than $20 Million in Equity Funding
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 16 Sep 2014
Dimension Therapeutics Names Annalisa Jenkins as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Jun 2014
Bayer HealthCare and Dimension Therapeutics to Develop Novel Gene Therapy for Hemophilia A
Biopharmaceuticals

HSMN NewsFeed - 23 Jun 2014
Dimension Therapeutics Raises $30M Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 28 Apr 2014
SI-BONE, Inc. Closes $33 Million Growth Capital Financing
Devices Orthopaedic Neurosurgery Venture Capital

HSMN NewsFeed - 13 Mar 2014
SAGE Therapeutics Closes $38M Oversubscribed Series C Financing
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 21 Feb 2014
GC Aesthetics raises $60M to Fund Global Growth and New Product Development
Devices Dermatology Venture Capital

HSMN NewsFeed - 13 Feb 2014
Principia Biopharma Expands Executive Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Jan 2014
Igenica Raises $14 Million in Additional Series C Funding to Advance Product Pipeline and Technology Platform
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 13 Jan 2014
Lilly Announces Acquisition of CGRP Antibody for Migraine Prevention from Arteaus Therapeutics
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 17 Dec 2013
ViewRay(TM) Closes a $30M Financing to Expedite Commercialization of its MRI-Guided Radiation Therapy System
Devices Oncology Venture Capital

HSMN NewsFeed - 1 Nov 2013
OrbiMed Launches $735 Million Venture Capital Fund
Devices Venture Capital

HSMN NewsFeed - 16 Oct 2013
Seragon Pharmaceuticals Raises $30M in Series A Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 3 Oct 2013
Loxo Oncology Raises $33 Million in Series A Financing to Fund Development of Small Molecule Oncology Drugs
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 12 Sep 2013
Medigus Announces Marketing Approval from the Israeli Ministry of Health (MEA) for SRS(TM) System for the Treatment of Gastroesophageal Reflux Disease (GERD)
Devices Gastroenterology Regulatory

HSMN NewsFeed - 11 Sep 2013
Cardioxyl Pharmaceuticals Appoints Shi Yin Foo, M.D., Ph.D., As Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Sep 2013
Keystone Heart's TriGuard(TM) Cerebral Protection Device Receives CE Marking
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 4 Sep 2013
Otonomy Completes $45.9 Million Series C Equity Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 3 Sep 2013
Arsanis Inc Closes $20 Million Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 13 Aug 2013
Medigus, Ltd. Announces Management Change: Board Approves the Appointment of Christopher Rowland as CEO
Devices Gastroenterology Personnel

HSMN NewsFeed - 18 Jul 2013
Audentes Therapeutics Raises $30 Million in Series A Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 25 Jun 2013
Acutus Medical, Inc. Raises $21 Million Toward its B-Series Financing
Devices Cardiology Venture Capital

HSMN NewsFeed - 9 Apr 2013
Cleave Biosciences Adds New Investor and $10 Million to Series A Financing
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 26 Mar 2013
Acceleron Receives Two FDA Orphan Designations for ACE-536
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 29 Oct 2012
Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 4 Oct 2012
Aragon Pharmaceuticals Raises $50 Million in Series D Financing to Advance Promising Therapeutic Candidates for Hormone-Driven Cancers
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 1 May 2012
Vessix Receives CE Mark For V2 Renal Denervation System(TM) For Treatment Of Hypertension
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 12 Apr 2012
Vessix Vascular Names Michael D. Gioffredi Chief Commercialization Officer
Devices Personnel

HSMN NewsFeed - 2 Apr 2012
Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team
Diganostics Venture Capital Personnel

HSMN NewsFeed - 13 Mar 2012
ViewRay Closes Round of Series C Financing
Devices Radiology Oncology Venture Captial

HSMN NewsFeed - 6 Mar 2012
Aragon Pharmaceuticals Secures $42 Million in Series C Financing to Advance Pipeline of Therapies Targeting Hormone-Driven Cancers
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 23 Dec 2011
Acceleron Secures $30M Private Financing
Biopharmaceuticals Mergers & Acquisitions Personnel

HSMN NewsFeed - 11 Oct 2011
Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 3 Aug 2011
Vessix Vascular Completes $23 Million Financing
Devices Interventional Venture Capital Personnel

HSMN NewsFeed - 21 Jul 2011
Aegerion Pharmaceuticals Announces Appointment of Paul G. Thomas to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Apr 2011
OrbiMed Promotes Four to Public Equity Partnership
Venture Capital Personnel

HSMN NewsFeed - 28 Feb 2011
Arsanis, Inc Announces Series A Financing with OrbiMed Advisors, Polaris Venture Partners and SV Life Sciences
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 21 Oct 2010
Cerenis Therapeutics raises additional €10 million to close €50 million Series C financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 17 Sep 2010
Eddingpharm (Cayman) Inc. Announces Closing of Series B Funding
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 13 Sep 2010
OrbiMed Expands Private Equity Team
Venture Capital Personnel

HSMN NewsFeed - 13 Sep 2010
Relypsa Raises $70 Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 9 Sep 2010
Shire Expands Pipeline to Treat Orphan Muscle Diseases Through Collaboration With Acceleron Pharma
Biopharmaceuticals Licensing

HSMN NewsFeed - 16 Aug 2010
Selecta Biosciences Appoints Werner Cautreels, Ph.D., as Company's First CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Jul 2010
Cerenis Therapeutics raises 40 million in series C financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 7 Jul 2010
DFine, Inc. Announces Close of $36 Million Funding
Devices Orthopaedic Neurosurgery Venture Capital

HSMN NewsFeed - 22 Apr 2010
Aragon Pharmaceuticals Secures $22 Million in Series B Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 5 Apr 2010
Selecta Closes $15 Million Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 22 Feb 2010
OrbiMed Launches $550 Million Venture Capital Fund
Biopharmaceuticals Devices Venture Capital

HSMN NewsFeed - 4 Jan 2010
Pieris Appoints a New CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Dec 2009
Acceleron Pharma Expands Management Team with Two New Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Nov 2009
Acceleron Pharma Initiates First-in-Human Study of ACE-041, a Novel Angiogenesis Inhibitor, in Patients with Advanced Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 13 Oct 2009
Amarin Announces Changes to Its Board and Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Sep 2009
PharmAbcine Closes USD $6 Million Series A Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 20 May 2009
Aragon Pharmaceuticals Announces $8 Million Series A Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 14 Apr 2009
ViewRay Incorporated Closes $15M Tranche of Series B Financing and Announces Partnership with Siemens AG
Devices Venture Capital

HSMN NewsFeed - 6 Apr 2009
Cerapedics Closes $15 Million Series B Financing
Devices Orthopaedic Venture Capital

HSMN NewsFeed - 12 Jan 2009
Singulex Closes $19 Million Financing Round
Diagnostics Venture Capital

HSMN NewsFeed - 20 Nov 2008
Adimab, Inc. Announces Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 6 Oct 2008
Biolex Therapeutics Completes $60 Million Series D Financing to Accelerate Development of Locteron(R) in Hepatitis C
Biopharmaceuticasl Venture Capital

HSMN NewsFeed - 25 Sep 2008
MacroGenics Raises $25M in Series D-2 Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 22 Sep 2008
Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jul 2008
Pacira Pharmaceuticals, Inc. Adds Board Member and Key Senior Management
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 May 2008
Apoptos Inc. Raises $28 Million in Series A Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 27 Mar 2008
Pieris Raises EUR 25 M (US$ 38 M) in Series B Financing Round
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 22 Jan 2008
ViewRay Incorporated Raises $25 Million in Series B Financing
Devices Venture Capital

HSMN NewsFeed - 4 Jan 2008
Cerimon Pharmaceuticals Names Matthew J. Meyer its General Counsel and Vice President of Business Development and Licensing
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Dec 2007
Pacira Pharmaceuticals Names David M. Stack CEO and President
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Nov 2007
SGX Pharmaceuticals Announces $25 Million Private Placement
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 14 Nov 2007
Ambit Biosciences Raises Over $49 Million in Series D Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 8 Nov 2007
Aspect Medical Systems, Inc. Announces Agreement with Boston Scientific to Waive Lock-up and Call Option on Remaining Shares Held by Boston Scientific
Devices Surgery Neurology Monitoring

HSMN NewsFeed - 30 Oct 2007
Acceleron Pharma Completes $31M Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 27 Sep 2007
Flynn Pharma Acquires Rights From Pacira Pharmaceuticals to DepoDur(R), the Only Extended-Release Epidural Opioid for Post-Operative Pain, in Europe
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 24 Sep 2007
Acceleron Pharma Appoints Niels Borgstein, M.D. as Vice President, Medical Research
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Sep 2007
Acceleron Pharma Appoints John L. Knopf, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Sep 2007
Enobia Pharma Raises $40.1 Million Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 20 Aug 2007
NeurAxon Announces $32 Million Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 15 Aug 2007
EKR Therapeutics Achieves Key Growth Milestone with the Acquisition of Rights from Pacira Pharmaceuticals to DepoDur(R), a Novel Extended-Release Opioid Analgesic for Post Operative Pain
Biopharmaceuticals Distribution

HSMN NewsFeed - 12 Jul 2007
Agensys Raises $41 Million
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 22 Jun 2007
SkyePharma Inc., Now a Private Pharmaceutical Company, Announces Name Change to Pacira Pharmaceuticals, Inc.
Biopharmaceuticals

HSMN NewsFeed - 25 Apr 2007
Acceleron Pharma Appoints James Desiderio, Ph.D. as Vice President, Program Management
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Apr 2007
FDA Grants Full Approval for DepoCyt(R) for the Treatment of Lymphomatous Meningitis
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 29 Mar 2007
Acceleron Pharma Appoints Robert Steininger as Senior Vice President, Manufacturing
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Feb 2007
Steven T. Sobieski Joins Insulet Corporation's Board of Directors
Devices Drug Delivery Personnel

HSMN NewsFeed - 9 Feb 2007
Targanta Announces $70 Million Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 11 Jan 2007
InteKrin Therapeutics Secures $23 M Venture Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 8 Jan 2007
Cerimon Pharmaceuticals Names Daniel Levitt, M.D., Ph.D. Executive Vice President of Research and Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Dec 2006
Cerexa to Be Acquired by Forest Laboratories for $480 Million Plus Potential $100 Million Milestone Payment
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 5 Dec 2006
Cerimon Pharmaceuticals Names Ayse Kocak Vice President of Marketing
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Nov 2006
Cerenis Therapeutics Closes EUR 42.1 Million Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 28 Sep 2006
Cerimon Pharmaceuticals Names Timothy J. McBride as Senior Vice President of Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Sep 2006
Innovative Spinal Technologies Names Frederic Moll, M.D., to Board of Directors
Devices Orthopaedic Neurosurgery Personnel

HSMN NewsFeed - 26 Sep 2006
Innovative Spinal Technologies Announces Launch of Paramount(TM) Pedicle Screw System for MIS Surgery
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 9 May 2006
YM Biosciences completes acquisition of Eximias
Biopharmaceuticals Oncology Mergers & Acquisitions

Return to NewsFeed

Additional items found! 23

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 23 additional stories matching:
OrbiMed
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.